Ranch Capital Advisors’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$244K Buy
+203
New +$207K 0.08% 144
2026
Q1
Sell
-203
Closed -$218K 159
2025
Q4
$218K Buy
+203
New +$194K 0.08% 143
2021
Q4
Sell
-145
Closed -$33K 372
2021
Q3
$33K Buy
145
+1
+0.7% +$247 0.02% 313
2021
Q2
$33K Hold
144
0.02% 381
2021
Q1
$26K Hold
144
0.02% 408
2020
Q4
$24K Buy
144
+1
+0.7% +$149 0.02% 429
2020
Q3
$21K Hold
143
0.02% 441
2020
Q2
$21K Hold
143
0.02% 458
2020
Q1
$19K Sell
143
-50
-26% -$6.87K 0.02% 451
2019
Q4
$25K Buy
+193
New +$22.4K 0.02% 468

Other funds holding LLY

Ranch Capital Advisors's LLY Position: Q2 2026 in Review

Ranch Capital Advisors opened a new position in Eli Lilly (LLY) in Q2 2026: 203 shares worth $244K. The stake represents 0.08% of the portfolio and ranks #144 among its holdings. This is a return to the name: Ranch Capital Advisors previously reported a position in LLY as recently as Q4 2025.

Ranch Capital Advisors first reported a position in LLY in Q4 2019 and has held it in 10 quarters since. 4,618 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Ranch Capital Advisors held 203 shares of Eli Lilly worth $244K as of Q2 2026.
  • Eli Lilly was a new Ranch Capital Advisors position in Q2 2026.
  • Eli Lilly made up 0.08% of Ranch Capital Advisors's portfolio in Q2 2026, its #144 holding.
  • Ranch Capital Advisors first reported a position in Eli Lilly in Q4 2019 and has held it in 10 quarters since.
  • 4,618 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Ranch Capital Advisors's 13F filing for Q2 2026, filed 3 Aug 2026.